Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.
about
A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serumAdvances in targeted proteomics and applications to biomedical researchExpediting SRM assay development for large-scale targeted proteomics experiments.Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoringProphylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.Liquid phase based separation systems for depletion, prefractionation, and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis-An update covering the period 2011-2014.Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum.Cerebrospinal fluid proteome of patients with acute Lyme diseaseThe clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsTargeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletionLong-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis.Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies.MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum.Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer.Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancerClinical applications of MS-based protein quantification.Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy.Rapidly maturing field of proteomics: a gateway to studying diseases.The age-specific reference intervals for tPSA, fPSA, and %fPSA in healthy Han ethnic male.Proteomics meets the scientific method.
P2860
Q24307894-08DF2D49-532E-4BA0-BC14-A1DD51D48300Q28066912-E3A9BF30-DBE7-4FBB-93BE-EB34EFBE44D2Q34286018-6D81AA90-6912-4B9C-9E7E-8392B82A7623Q34810177-FFA0AE86-777A-42DA-B609-2273EA86D145Q35761001-5EED0988-72E8-4D13-91BA-EB8EFCC1516EQ35799972-89E80C8B-687E-4D0C-B502-43823D0990B2Q36280125-F4286407-F89B-47AC-A127-D89CBE675341Q36301174-C23940DD-E357-46B0-AB17-32D520A4BA74Q36771005-F07BD7EA-3F3E-4D9E-9491-5A720932791DQ36889137-77951655-262C-4513-8477-0CEB2B021B12Q37069906-E938655E-507A-4E3C-8434-D16BA014AA88Q37341145-834336E9-D814-4ED5-B7AA-ED0F338EF1F4Q38160931-487A0F92-1BD4-4E7A-8FC5-695B215C37F6Q38164428-7000C846-8E73-44ED-9F41-70F5C17EA444Q38183147-BD92C491-2B3A-4B40-9533-05AE31DD5C45Q38188878-0996C1BF-57FA-4531-855B-973EDFD9D3CDQ38604366-951775D0-A2C5-4FE7-B02A-A2689CEB7968Q38672374-79769C1E-B559-459F-9884-0C1DE251ED72Q38802991-2AB9560C-2E19-4276-B25F-AD2733EE9BB7Q39099850-09EBD137-FEC9-4994-A8AD-046D67ABE29DQ47660938-CA6FD7B8-80C6-430D-B032-3554735FE88BQ50125224-24364D47-AFA9-47A9-8D5F-3937CD06E381Q51488592-43D83C21-63DA-4674-8890-C3CEDA30314FQ55056925-CF8BF36D-21E8-4A27-8AEF-60656ECE0117
P2860
Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Analysis of serum total and fr ...... th clinical immunoassay tests.
@ast
Analysis of serum total and fr ...... th clinical immunoassay tests.
@en
type
label
Analysis of serum total and fr ...... th clinical immunoassay tests.
@ast
Analysis of serum total and fr ...... th clinical immunoassay tests.
@en
prefLabel
Analysis of serum total and fr ...... th clinical immunoassay tests.
@ast
Analysis of serum total and fr ...... th clinical immunoassay tests.
@en
P2093
P2860
P50
P1476
Analysis of serum total and fr ...... th clinical immunoassay tests.
@en
P2093
Daniel W Chan
David G Camp
Grant Izmirlian
Ian M Thompson
Jacob Kagan
Karin D Rodland
Lori J Sokoll
Mahmud Hossain
Robin J Leach
Scott R Kronewitter
P2860
P304
P356
10.1016/J.JPROT.2012.01.035
P577
2012-02-13T00:00:00Z